Connie Seeley is a new ex-officio board member for the Portland Metro Chamber of Commerce.

In a story about more hospitals billing some patients when their providers respond to requests sent via electronic messages, Anthony Cheng, M.D., discusses how since February OHSU has billed for complex electronic patient requests that require more provider time and expertise, noting: “This is part of a broader conversation about expectations patients and providers have of each other.”

Sky Lakes Medical Center congratulates and thanks the eight graduating residents of the joint OHSU-Sky Lakes Cascades East Family Medicine Residency Program, three of whom are staying in Klamath Falls to be providers at the clinic associated with the program.

Mathew Geltzeiler, M.D., co-moderates a session at the American Head & Neck Society Annual Meeting on outcomes for oral cancer patients who delayed radiation treatment. In an interview with MedPage Today, he says at OHSU, there is a nurse navigator who works with patients and doctors to schedule follow-up, but "sometimes, the hold-up can be the patients themselves," as they may have travel constraints, be reluctant to proceed after surgery, or have personal events or other factors that contribute to delays.

A new study finds nearly half of Black men were diagnosed with skin cancer when it was already in an advanced stage, compared with about one in five white men. Alexander Witkowski, M.D., and Joanna Ludzik, M.D., provide tips and tricks for catching skin cancer as early as possible.

Mathew Geltzeiler, M.D., co-moderates a session at the American Head & Neck Society Annual Meeting on outcomes for oral cancer patients who delayed radiation treatment. In an interview with MedPage Today, he says at OHSU, there is a nurse navigator who works with patients and doctors to schedule follow-up, but "sometimes, the hold-up can be the patients themselves," as they may have travel constraints, be reluctant to proceed after surgery, or have personal events or other factors that contribute to delays.

The development of the drug Gleevec and the work of Brian Druker, M.D., is featured in a video series from the Lasker Foundation on the 75+ Lasker Laureates “whose discoveries have mightily advanced the war on cancer.”

A viewpoint by OHSU addiction medicine experts, which says the addiction treatment system is "inflexible" and practices "create life-threatening barriers to care," is cited in a Psychology Today column that says progress is being made, and explains five ways the health system is lowering barriers to addiction care.

In an interview with Advanced Science News, Shannon McWeeney, Ph.D., provides comment on a study that has identified a specific epigenetic signature in the cancer cells of leukemia patients who respond to a new anti-cancer treatment. McWeeney speaks to the need for health equity: “In countries or even rural areas of the US, where infrastructure and resources can be more limited, we know that there are large disparities in cancer deaths.”

The BBC Panorama program interviews Erick Turner, M.D., in a story exploring whether the current generation of antidepressant medications have lived up to their promises.